Effects of interferon-γ and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells

Cytokine

Volumn 55, Issue 3, 2011, Pages 330-334

  Katragkou, Aspasia ^a   Simitsopoulou, Maria ^a   Chatzimoschou, Athanasios ^a   Georgiadou, Elpiniki ^a   Walsh, Thomas J ^b,c   Roilides, Emmanuel ^a,b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Biofilm; Candida albicans; G CSF; IFN ; Neutrophils

Indexed keywords

GAMMA INTERFERON; IMUKINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; FUNGUS GROWTH; FUNGUS IMMUNITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; NONHUMAN; PHENOTYPE; PLANKTON; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; NEUTROPHILS; PLANKTON;

CANDIDA; CANDIDA ALBICANS;

EID: 79960890199     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.05.007     Document Type: Article

References (22)

1. Leroy O., Gangneux J.P., Montravers P., Mira J.P., Gouin F., Sollet J.P., et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009, 37:1612-1618.
2. Douglas L.J. Candida biofilms and their role in infection. Trends Microbiol 2003, 11:30-36.
3. Katragkou A., Kruhlak M.J., Simitsopoulou M., Chatzimoschou A., Taparkou A., Cotten C.J., et al. Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. J Infect Dis 2010, 201:1941-1949.
4. Chandra J., McCormick T.S., Imamura Y., Mukherjee P.K., Ghannoum M.A. Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines. Infect Immun 2007, 75:2612-2620.
5. Shoham S., Levitz S.M. The immune response to fungal infections. Br J Haematol 2005, 129:569-582.
6. Roilides E., Walsh T. Recombinant cytokines in augmentation and immunomodulation of host defenses against Candida spp. Med Mycol 2004, 42:1-13.
7. Gil-Lamaignere C., Winn R.M., Simitsopoulou M., Maloukou A., Walsh T.J., Roilides E. Interferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: comparison with Aspergillus spp. Med Mycol 2005, 43:253-260.
8. Roilides E., Holmes A., Blake C., Pizzo P.A., Walsh T.J. Effects of granulocyte colony-stimulating factor and interferon-gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species. J Leukoc Biol 1995, 57:651-656.
9. Roilides E., Walsh T.J., Pizzo P.A., Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991, 163:579-583.
10. Bonilla M.A., Gillio A.P., Ruggeiro M., Kernan N.A., Brochstein J.A., Abboud M., et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989, 320:1574-1580.
11. Ramage G., Vande Walle K., Wickes B.L., Lopez-Ribot J.L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001, 45:2475-2479.
12. Katragkou A., Chatzimoschou A., Simitsopoulou M., Dalakiouridou M., Diza-Mataftsi E., Tsantali C., et al. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother 2008, 52:357-360.
13. Meshulam T., Levitz S.M., Christin L., Diamond R.D. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT). J Infect Dis 1995, 172:1153-1156.
14. Djeu J.Y., Blanchard D.K., Halkias D., Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol 1986, 137:2980-2984.
15. Morrison C.J., Brummer E., Isenberg R.A., Stevens D.A. Activation of murine polymorphonuclear neutrophils for fungicidal activity by recombinant gamma interferon. J Leukoc Biol 1987, 41:434-440.
16. Buckle A.M., Hogg N. The effect of IFN-gamma and colony-stimulating factors on the expression of neutrophil cell membrane receptors. J Immunol 1989, 143:2295-2301.
17. Netea M.G., Brown G.D., Kullberg B.J., Gow N.A. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 2008, 6:67-78.
18. Leid J.G., Willson C.J., Shirtliff M.E., Hassett D.J., Parsek M.R., Jeffers A.K. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J Immunol 2005, 175:7512-7518.
19. Netea M.G., Brouwer A.E., Hoogendoorn E.H., Van der Meer J.W., Koolen M., Verweij P.E., et al. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-gamma therapy. Clin Infect Dis 2004, 39:e83-e87.
20. Vonk A.G., Netea M.G., van der Meer J.W., Kullberg B.J. Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy. Expert Opin Biol Ther 2006, 6:891-903.
21. Marciano B.E., Wesley R., De Carlo E.S., Anderson V.L., Barnhart L.A., Darnell D., et al. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 2004, 39:692-699.
22. van Spriel A.B., van den Herik-Oudijk I.E., van de Winkel J.G. A single injection of polyethylene-glycol granulocyte colony-stimulating factor strongly prolongs survival of mice with systemic candidiasis. Cytokine 2000, 12:666-670.